|
|
|
|
|
|
|
Onconova Therapeutics- Inc. (ONTX)
|
|
0.41 0 (0%)
|
08-17 16:00
|
|
Open:
|
0.4123
|
Pre. Close:
|
0.41
|
|
High:
|
0.4249
|
Low:
|
0.405
|
|
Volume:
|
113,370
|
Market Cap:
|
32M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.42 - 0.423
|
0.423 - 0.426
|
|
Low:
|
0.404 - 0.408
|
0.408 - 0.41
|
|
Close:
|
0.406 - 0.411
|
0.411 - 0.414
|
|
|
|
Technical analysis (as of: 2018-08-17 4:28:53 PM)
|
|
Overall:
|
 
|
|
Stoxline posted a NEUTRAL today, upgraded from lower rating. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next BUY or SELL signal.
|
|
Target:
|
Six months: 0.54 One year: 0.58
|
|
Support:
|
Support1: 0.40 Support2: 0.33
|
|
Resistance:
|
Resistance1:
0.46 Resistance2: 0.50
|
|
Pivot:
|
0.44 
|
|
Moving Averages:
|
MA(5): 0.41 MA(20): 0.44
MA(100): 0.50 MA(250): 1.15
|
|
MACD:
|
MACD(12,26):
-0.01 Signal(12,26,9): -0.01
|
|
%K %D:
|
%K(14,3): 12.50 %D(3): 13.10
|
|
RSI:
|
RSI(14): 40.24
|
|
52-Week:
|
High: 2.83
Low: 0.33 Change(%): -73.7
|
|
Average Vol(K):
|
3-Month: 240580
10-Days 58374
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.ONTX has closed above bottom band by 16.8%. Bollinger Bands are 61.7% narrower than normal. The narrow width of the bands suggests low volatility as compared to ONTX's normal range. The bands have been in this narrow range for 28 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-08-14T12:49:03-04:00
Onconova Therapeutics, Inc. (ONTX) CEO Ramesh Kumar on Q2 2018 Results - Earnings Call Transcript
2018-08-14T09:06:22-04:00
Onconova Therapeutics Q2 revenues up 67%; shares up 5% premarket
2018-08-14T08:03:13-04:00
Onconova Therapeutics beats by $0.01, beats on revenue
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
